FDA Halts Drug Production at Ranbaxy Plant

The agency has ordered the Toansa, India facility of Ranbaxy to halt drug production and distribution.

According to a press release from FDA, the agency has ordered the Toansa, India facility of Ranbaxy to halt all drug production and distribution for the U.S. market. The company is specifically prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs), and the Toansa facility is added to an existing consent decree initially entered against the company in January 2012.

The decree contains provisions to ensure the company complies with current good manufacturing practice requirements at facilities in Paonta Sahib and Dewas, India. FDA added Ranbaxy's Mohali facility in September 2013.

The action taken by FDA comes in the wake of an inspection of the Toansa facility on Jan. 11, 2014. FDA's inspection found several violations, in particular Toansa staff's retesting raw materials, intermediate drug products, and finished API after the items failed analytical testing and then subsequently not reporting the failures. Ranbaxy has been ordered to hire a third-party expert to inspect the Toansa facility.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Analyze Incident Data

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January / February 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue